From where I sit, we work with experts in evaluation and experts in this field to undertake third party evaluation of these programs.
I'm certainly happy to turn it over to Dr. Weiss to talk about some of what is being looked at in terms of the current third party evaluation of some of our prescribed pharmaceutical alternatives programs.